Mersen S.A.
Mersen S.A. Fundamental Analysis
Mersen S.A. (CBLNY) shows weak financial fundamentals with a PE ratio of 19.43, profit margin of 3.76%, and ROE of 4.23%. The company generates $0.9B in annual revenue with weak year-over-year growth of 2.70%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 31.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze CBLNY's fundamental strength across five key dimensions:
Efficiency Score
WeakCBLNY struggles to generate sufficient returns from assets.
Valuation Score
ExcellentCBLNY trades at attractive valuation levels.
Growth Score
WeakCBLNY faces weak or negative growth trends.
Financial Health Score
ExcellentCBLNY maintains a strong and stable balance sheet.
Profitability Score
WeakCBLNY struggles to sustain strong margins.
Key Financial Metrics
Is CBLNY Expensive or Cheap?
P/E Ratio
CBLNY trades at 19.43 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, CBLNY's PEG of -0.55 indicates potential undervaluation.
Price to Book
The market values Mersen S.A. at 0.85 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 2.60 times EBITDA. This is generally considered low.
How Well Does CBLNY Make Money?
Net Profit Margin
For every $100 in sales, Mersen S.A. keeps $3.76 as profit after all expenses.
Operating Margin
Core operations generate 7.49 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $4.23 in profit for every $100 of shareholder equity.
ROA
Mersen S.A. generates $1.90 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Mersen S.A. produces operating cash flow of $175.38M, showing steady but balanced cash generation.
Free Cash Flow
Mersen S.A. generates weak or negative free cash flow of $25.05M, restricting financial flexibility.
FCF Per Share
Each share generates $0.21 in free cash annually.
FCF Yield
CBLNY converts 3.86% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
19.43
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.55
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.85
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.72
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.59
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.39
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.04
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.05
vs 25 benchmark
How CBLNY Stacks Against Its Sector Peers
| Metric | CBLNY Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 19.43 | 26.11 | Better (Cheaper) |
| ROE | 4.23% | 1298.00% | Weak |
| Net Margin | 3.76% | -34100.00% (disorted) | Weak |
| Debt/Equity | 0.59 | 0.81 | Strong (Low Leverage) |
| Current Ratio | 1.39 | 10.62 | Neutral |
| ROA | 1.90% | -1540438.00% (disorted) | Weak |
CBLNY outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Mersen S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
16.48%
Industry Style: Cyclical, Value, Infrastructure
High GrowthEPS CAGR
-8.36%
Industry Style: Cyclical, Value, Infrastructure
DecliningFCF CAGR
40.26%
Industry Style: Cyclical, Value, Infrastructure
High Growth